-
2024-510873-11-00
4
Borderline personality disorder
-
2024-513724-42-00
10
Medulloblastoma
-
2024-516734-35-00
5
triple-negative early breast cancer
-
2024-517133-40-00
5
newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC ampli
-
2024-517295-37-00
5
low and intermediate risk neuroblastoma
-
2024-518026-32-00
5
Invasive Breast Cancer
-
2024-520068-32-00
6
Type 2 diabetes
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
-
2025-523259-72-00
5
Hidradenitis Suppurativa (HS)
-
2025-523404-74-00
4
2026-05-26
Prurigo Nodularis
-
2025-524265-24-00
5
2026-05-21
Dyslipidemia at High to Very High Cardiovascular Risk
-
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
-
2025-522484-15-00
5
2026-04-27
ER+/HER2- early breast cancer
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521276-59-00
5
2025-12-16
Autosomal dominant polycystic kidney disease (ADPKD)
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2025-521040-37-00
5
2025-11-26
HER2-positive early breast cancer
-
2025-520582-51-00
5
2025-10-17
Hormone receptor positive breast cancer
-
2024-520107-12-00
5
2025-09-03
Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2023-506605-19-00
5
2025-02-11
Bipolar depression
-
2024-511879-16-00
5
2024-12-12
Prurigo Nodularis
-
2023-506602-39-00
6
2024-08-01
schizophrenia, schizoaffective disorder, schizophrenifom disorder